Correlation Between INtRON Biotechnology and Medy Tox
Can any of the company-specific risk be diversified away by investing in both INtRON Biotechnology and Medy Tox at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INtRON Biotechnology and Medy Tox into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iNtRON Biotechnology and Medy Tox, you can compare the effects of market volatilities on INtRON Biotechnology and Medy Tox and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INtRON Biotechnology with a short position of Medy Tox. Check out your portfolio center. Please also check ongoing floating volatility patterns of INtRON Biotechnology and Medy Tox.
Diversification Opportunities for INtRON Biotechnology and Medy Tox
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between INtRON and Medy is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding iNtRON Biotechnology and Medy Tox in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medy Tox and INtRON Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iNtRON Biotechnology are associated (or correlated) with Medy Tox. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medy Tox has no effect on the direction of INtRON Biotechnology i.e., INtRON Biotechnology and Medy Tox go up and down completely randomly.
Pair Corralation between INtRON Biotechnology and Medy Tox
Assuming the 90 days trading horizon iNtRON Biotechnology is expected to generate 0.5 times more return on investment than Medy Tox. However, iNtRON Biotechnology is 2.01 times less risky than Medy Tox. It trades about -0.07 of its potential returns per unit of risk. Medy Tox is currently generating about -0.26 per unit of risk. If you would invest 585,000 in iNtRON Biotechnology on August 29, 2024 and sell it today you would lose (22,000) from holding iNtRON Biotechnology or give up 3.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
iNtRON Biotechnology vs. Medy Tox
Performance |
| Timeline |
| iNtRON Biotechnology |
| Medy Tox |
INtRON Biotechnology and Medy Tox Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with INtRON Biotechnology and Medy Tox
The main advantage of trading using opposite INtRON Biotechnology and Medy Tox positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INtRON Biotechnology position performs unexpectedly, Medy Tox can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medy Tox will offset losses from the drop in Medy Tox's long position.| INtRON Biotechnology vs. Medy Tox | INtRON Biotechnology vs. Busan Industrial Co | INtRON Biotechnology vs. Busan Ind | INtRON Biotechnology vs. Mirae Asset Daewoo |
| Medy Tox vs. Busan Industrial Co | Medy Tox vs. Busan Ind | Medy Tox vs. Mirae Asset Daewoo | Medy Tox vs. UNISEM Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |